GoHealth, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GoHealth, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($257.13M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.93M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($63.26M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($148.71M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($189.36M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($44.27M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | $16.00M | Mar 16, 2022 |
| FY2021 | Sep 12, 2019 | ($57.06M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $28.12M | Mar 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($412.90M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($7.05M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($81.68M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($318.67M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($489.45M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($64.55M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | $24.10M | Mar 16, 2022 |
| FY2021 | Sep 12, 2019 | ($56.88M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $28.76M | Mar 16, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($121.95M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($21.61M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $109.14M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $60.90M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($299.01M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | ($114.22M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | ($9.28M) | Mar 16, 2022 |
| FY2021 | Sep 12, 2019 | $9.28M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $5.44M | Mar 16, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $987.38M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.49B | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.50B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.66B | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $2.07B | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.11B | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $1.60B | Mar 16, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.87M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $241.84M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $231.01M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $268.76M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $353.10M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $380.42M | Mar 16, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Mar 16, 2022 |
| FY2021 | Dec 31, 2020 | $386.55M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $386.55M | Mar 16, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($680.33M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($423.21M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($420.28M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($357.02M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($208.32M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($18.80M) | Mar 16, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.90M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $40.92M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $90.81M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $16.46M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $84.36M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $144.23M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $12.28M | Mar 16, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $636.74M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $487.37M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $497.71M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $510.08M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $670.39M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $400.57M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $291.23M | Mar 16, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (20) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | (7) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | (17) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | (26) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 23, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (20) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | (7) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | (17) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | (26) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 23, 2023 |